Details for: CL0000839

Cell ID: CL0000839

Cell Name: myeloid lineage restricted progenitor cell

Description: Note that this is a class of cell types, not an identified single cell type.

Synonyms: myeloid progenitor cell

Selected Context(s): Overall

Gene Significance Landscape

Display Options
Score:
Display
Genes

Contexts:

Cell Significance Index (CSI) is uniquely calculated to reveal cell-specific gene markers. More info here

Significant Genes List

Genes with the highest and lowest Percentile Rank Scores (PRS) for myeloid lineage restricted progenitor cell within the selected context(s).

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for myeloid lineage restricted progenitor cell. Higher scores indicate a stronger, more significant difference in expression.
(Previously described as "Fold Change", but now represents Cliff's Delta × –log10(p).)

Gene ID: A unique numerical identifier for this specific gene.
Symbol: Shortened abbreviation or name that represents this gene.
Ensembl Gene ID: A unique identifier assigned by Ensembl for genomic data mapping.
CSI Score: A combined effect size and statistical significance measure for myeloid lineage restricted progenitor cell. Higher scores indicate a stronger, more significant difference in expression.
Average CSI: csi sum / gene count
Cell network configuration

This network visualizes key genes for myeloid lineage restricted progenitor cell. It primarily includes:
1. Top genes highly significant for this cell (Num. Top Cell Genes - based on the 'Min. CSI' setting).
2. Any additional specific 'Context Genes' you add below.
The final network is a combined view. Choose an Interaction Source (pathways or protein interactions) and optionally compare CSI scores with a Baseline Cell Type.

Maximum number of selected genes.
Select a context for the baseline cell.
Select a context for the target cell.
Target Cell for CSI:  myeloid lineage restricted progenitor cell (CL0000839)

 Legend
Nodes (Genes):
 Query Gene
Node size also reflects Target Cell CSI magnitude.
Node Color (Target Cell CSI in specific network):
 Very High
 High
 Medium
 Low
 Very Low
 N/A or Not Sig.
Edges (Interactions):
 STRING (Protein-Protein)
 ONTOLOGY (Shared Pathway)
 Colors vary by pathway category; default arrow applies.

Loading network (please wait)...

## Summary The [myeloid lineage restricted progenitor cell](/details-cell/CL0000839) represents a class of multipotent cells responsible for generating the diverse lineages of myeloid cells, including granulocytes, monocytes, erythrocytes, and megakaryocytes. Based on gene significance analysis, the **Overall** defining characteristic of this progenitor state is an exceptionally strong and specific expression of a vast array of proteins involved in RNA processing. This suggests that the maintenance of its undifferentiated state and the potential for lineage commitment are intricately controlled at the post-transcriptional level through mechanisms such as mRNA splicing and stability. ## Key Characteristics and Function Analysis of gene expression specificity reveals several core functional themes that characterize [myeloid lineage restricted progenitor cells](/details-cell/CL0000839). * **Dominance of RNA Processing and Splicing Machinery:** The most striking feature is the high cell-type specificity of numerous heterogeneous nuclear ribonucleoproteins (hnRNPs) and splicing factors. Top markers include [HNRNPA2B1](/details-gene/3181), [HNRNPC](/details-gene/3183), [RBM39](/details-gene/9584), [HNRNPU](/details-gene/3192), [HNRNPDL](/details-gene/9987), and [HNRNPA3](/details-gene/220988). This group is further complemented by other key RNA processing molecules like the RNA helicase [DDX5](/details-gene/1655) and the splicing factor [SRSF5](/details-gene/6430). This extensive and highly specific toolkit for RNA metabolism indicates that alternative splicing and the regulation of mRNA stability are central mechanisms governing gene expression in these cells. This plasticity is crucial for maintaining a balance between self-renewal and readiness for differentiation into multiple downstream lineages. * **High Metabolic Activity and Protein Homeostasis:** These progenitors are metabolically active, as indicated by the specific expression of genes involved in core metabolic pathways, such as [GAPDH](/details-gene/2597), and components of the mitochondrial respiratory chain like [COX2](/details-gene/4513) and [CYTB](/details-gene/4519). Concurrently, genes involved in protein turnover and quality control, such as the ubiquitin-conjugating enzyme [UBE2D3](/details-gene/7323) and ubiquitin B ([UBB](/details-gene/7314)), are also highly specific. This suggests a tightly regulated proteome, essential for managing the rapid cellular changes associated with proliferation and differentiation. * **Transcriptional and Chromatin Regulation:** The identity of these cells is also supported by the specific expression of factors that modulate chromatin structure and transcription. [HMGB1](/details-gene/3146), a non-histone chromosomal protein, and [YBX1](/details-gene/4904), which binds to both DNA and RNA, point to the importance of maintaining an accessible and dynamic chromatin state, a hallmark of progenitor cells. * **Defining by Absence of Specialization:** The anti-markers, or genes with the lowest expression specificity, provide critical context. The low specificity of canonical proliferation markers like [MKI67](/details-gene/4288) and DNA replication factors ([MCM6](/details-gene/4175), [GMNN](/details-gene/51053)) suggests that while these cells proliferate, this function is not their unique identifier compared to other proliferating cell types. Furthermore, the low specificity of mature myeloid effector genes such as [AZU1](/details-gene/566) (azurocidin) confirms their progenitor status, as they are not yet committed to a terminal cell fate. ## Clinical Significance and Contextual Roles **Overall**, the profound reliance of [myeloid lineage restricted progenitor cells](/details-cell/CL0000839) on RNA processing machinery has significant clinical implications, particularly in the context of hematological malignancies. The dysregulation of splicing factors is a known driver of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Many of the top marker genes identified here, including members of the HNRNP family ([HNRNPA2B1](/details-gene/3181), [HNRNPC](/details-gene/3183)) and other RNA-binding proteins ([RBM39](/details-gene/9584)), are implicated in cancer pathogenesis. For example, some hnRNPs are known to regulate the splicing of key oncogenes or tumor suppressors ([Link](https://pubmed.ncbi.nlm.nih.gov/2557628/)). The high specificity of this machinery in myeloid progenitors suggests that these cells may be particularly vulnerable to mutations in these genes, leading to aberrant differentiation and malignant transformation. Therefore, this suite of RNA-processing proteins could serve as a source of biomarkers for early detection of myeloproliferative disorders or as potential therapeutic targets for drugs that modulate splicing factor activity. ## Potential Mechanisms and Research Directions 1. **Hypothesis: Myeloid progenitor fate is controlled by a post-transcriptional "splicing code."** The high specificity of a large cohort of hnRNPs and other splicing factors ([HNRNPA2B1](/details-gene/3181), [SRSF5](/details-gene/6430), [DDX5](/details-gene/1655)) suggests that these cells use a complex program of alternative mRNA splicing to maintain pluripotency and prime for lineage commitment. This "splicing signature" could generate specific protein isoforms that actively repress differentiation or prepare transcripts of lineage-specific genes for rapid translation upon receiving external cues, acting as a primary layer of cell fate regulation. * **Surprising Findings:** It is notable that the defining molecular signature of this progenitor cell is dominated by post-transcriptional regulators rather than the transcription factors or cell surface markers more traditionally used for cell identification. The sheer number and high specificity of these RNA-binding proteins suggest a level of regulatory complexity at the RNA level that may be a more fundamental aspect of its identity than previously appreciated. * **Testable Questions:** Does RNA-sequencing analysis of [myeloid lineage restricted progenitor cells](/details-cell/CL0000839) reveal a unique global pattern of alternative splicing events? Furthermore, does targeted knockdown of top-ranked splicing factors like [HNRNPA2B1](/details-gene/3181) or [RBM39](/details-gene/9584) skew the differentiation of these progenitors towards one myeloid lineage over others? 2. **Hypothesis: A specialized mitochondrial program regulates progenitor state.** The differential specificity observed among mitochondrial genes, where components like [COX2](/details-gene/4513) and [CYTB](/details-gene/4519) are highly specific markers while others like [COX3](/details-gene/4514) and [ND1](/details-gene/4535) are not, suggests a tailored metabolic program. This program may not simply reflect a high energy demand but could be structured to produce specific metabolic intermediates that act as epigenetic modifiers (e.g., acetyl-CoA for histone acetylation), thereby directly linking the cell's metabolic state to the maintenance of its progenitor identity and chromatin plasticity. * **Surprising Findings:** The observation that individual subunits of the same mitochondrial respiratory complexes exhibit starkly different expression specificities is unexpected. This may indicate a non-canonical function or regulation of these specific subunits, or perhaps a unique stoichiometry of the respiratory chain complexes that is adapted to the specific needs of a myeloid progenitor. * **Testable Questions:** Using metabolic flux analysis, can a distinct metabolic signature be identified in [myeloid lineage restricted progenitor cells](/details-cell/CL0000839) compared to their differentiated progeny? Does pharmacological or genetic inhibition of specifically upregulated components, such as [COX2](/details-gene/4513), alter the epigenetic landscape (e.g., histone acetylation levels) and impact the self-renewal or differentiation capacity of these cells?